Difference between revisions of "Team:Shenzhen SFLS/Attributions"

Line 337: Line 337:
  
 
   </div>
 
   </div>
 +
</div>
 
   <br/><br/><br/>
 
   <br/><br/><br/>
  
Line 350: Line 351:
 
<p>Dr. Cheng, a doctor from Peking Shenzhen University Hospital, attended our interview on various aspects including treatment of Melanoma and prospect of Crispr.</p>
 
<p>Dr. Cheng, a doctor from Peking Shenzhen University Hospital, attended our interview on various aspects including treatment of Melanoma and prospect of Crispr.</p>
 
<p>Claudia C.Agnew,a physician assistant, clarified us with the current situation and prospect of gene therapy and melanoma.</p>
 
<p>Claudia C.Agnew,a physician assistant, clarified us with the current situation and prospect of gene therapy and melanoma.</p>
  <br/><br/><br/>
+
</div>
 +
<br/><br/><br/>
  
 
<div class="row">
 
<div class="row">
Line 363: Line 365:
 
           </br>
 
           </br>
 
<p>On 29th July,we borrowed our lecture venue from Book City, and three members of our team gave speeches for the public.  </p>
 
<p>On 29th July,we borrowed our lecture venue from Book City, and three members of our team gave speeches for the public.  </p>
  <br/><br/><br/>
+
</div>
 +
<br/><br/><br/>
  
 
<div class="row">
 
<div class="row">

Revision as of 12:03, 1 November 2017

Team:Shenzhen SFLS/Demonstrate - 2017.igem.org

Team:Shenzhen SFLS/Attributions - 2017.igem.org